Home > Insider Trading > Filing (0001104659-15-066589)

Filing Details

Accession Number:: 0001104659-15-066589
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2015-09-23 06:00:41
Reporting Period:: 2015-04-29

Filing Date:: 2015-09-23
Accepted Time:: 2015-09-23 06:00:41
Original Submission Date:: 2015-04-30
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1436304	Kythera Biopharmaceuticals Inc	KYTH	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1559583	W John Smither	C/O Kythera Biopharmaceuticals, Inc. 30930 Russell Ranch Road, 3Rd Floor Westlake Village CA 91362	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-04-29	5,409	$0.00	5,409	No	4	A	Direct
Common Stock	Disposition	2015-04-30	2,041	$45.49	3,368	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	12,216	Indirect	See Footnote

Footnotes

On January 22, 2014, the Reporting Person was granted 5,409 restricted stock units (RSUs), with 100% of the RSUs to vest upon approval of the Issuer's New Drug Application (NDA) by the U.S. Food and Drug Administration. The NDA was approved on April 29, 2015. The Reporting Person received one (1) share of Common Stock for each one (1) RSU upon vesting.
The purpose of this amendment is to report correctly the number of securities beneficially owned by the Reporting Person following the transactions reported in the original Form 4 filed with the Securities and Exchange Commission on April 30, 2015. The Reporting Person's indirect ownership of 12,216 shares was incorrectly reported as direct ownership on the original Form 4, and the subsequent Form 4 filed by the Reporting Person on June 30, 2015. Except as otherwise noted in this Form 4/A, all other information disclosed in the Reporting Person's original Form 4 was accurately reported.
Sale of shares to satisfy tax withholding obligations in connection with the vesting of the RSUs.
The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $45.05 to $45.79, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Shares held by the 1994 Smither Family Trust dated March 1, 1994 as amended March 23, 2006, John W. Smither and Noretha V. Smither, Trustees (the "1994 Smither Family Trust").